Screening

Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.

womanconsultation.jpg

Personalized breast cancer risk assessment could reduce overdiagnosis

Personalized breast cancer screening programs could help women better understand their personal cancer risks and guide providers in recommending mammographic assessments based on these risks. 

Brian Lindman, MD, MSCI, medical director of the Structural Heart and Valve Center and an associate professor of medicine, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program. It was announced at the AHA 2022 meeting and is designed to help screen with echo to find more AS patients.

VIDEO: AHA says aortic stenosis is undertreated and underdiagnosed

Brian Lindman, MD, medical director of the Structural Heart and Valve Center, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program to screen with echo to find more AS patients. 

Thumbnail

Why some women tend to overestimate their breast cancer risks

For women with dense breasts, it can be particularly challenging to differentiate between actual and perceived breast cancer risks.  

Thumbnail

What factors influence low follow-up adherence after a positive LDCT cancer screening?

Experts are calling for strategies to improve follow-up adherence among individuals who have positive lung cancer screenings after a new analysis revealed low rates of compliance. 

Advances in computed tomography scanner (CT) technology include photon-counting (Siemens image left) and faster, higher slice CT systems with integrated AI. Right image is GE Healthcare's Revolution on display at SCCT 2022. Trends in CT imaging by Signify Research.

VIDEO: CT imaging market trends and advances overview by Signify Research

Bhvita Jani, research manager, Signify Research, explains key trends and technology advances in the computed tomography (CT) market. 

The FDA tracks mammography systems and the number of exams performed in the U.S. through its Mammography Quality Standards Act (MQSA) program. This is an example of the GE Senobright HD imaging system.

Is contrast-enhanced mammography suitable for women with breast implants?

A new paper highlights several studies supporting the use of screening mammography for women with breast implants, as well as additional considerations that need to be made for these patients.  

Thumbnail

More than 6,000 mammograms reviewed after radiology group misses dozens of cancers

Cancer was identified in an additional 25 women, all of whom required either surgery, chemotherapy, radiation or a mastectomy. 

Thumbnail

Should breast cancer screening initiation ages be reconsidered for women with a family history?

Suggesting that the standard 10-year age gap screening rule might not be as beneficial as previously assumed, researchers have indicated that women with relatives diagnosed at younger ages should consider different screening criteria.

Around the web

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Elucid's PlaqueIQ was trained to turn CCTA images into interactive 3D reports that help physicians visualize the presence of atherosclerosis.

Trimed Popup
Trimed Popup